Align Technology ( (ALGN) ) has released its Q4 earnings. Here is a breakdown of the information Align Technology presented to its investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Align Technology, Inc. is a global medical device company specializing in the design, manufacture, and sale of the Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry.
The company recently announced its financial results for the fourth quarter and fiscal year 2024, highlighting total revenues of $995.2 million for Q4 and $4.0 billion for the full year, with a notable increase in both clear aligner volumes and system services revenues.
Key financial metrics included a 3.5% year-over-year increase in total revenues for 2024, with clear aligner revenues reaching $3.2 billion. The company’s operating margin was 15.2%, although impacted by foreign exchange rates. Align repurchased $352.9 million in common stock and invested $30 million in Smile Doctors.
Align Technology’s management remains optimistic, anticipating low single-digit revenue growth for 2025, despite potential challenges related to foreign exchange and tariffs. The company plans to continue expanding its product offerings and enhancing its global business operations.
Looking forward, Align Technology aims to leverage its technological innovations and strategic investments to maintain growth and deliver value to shareholders, while navigating the dynamic market conditions expected in 2025.
